Compare Stocks: STXS, NPCE, SENS, and RCEL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NPCE NeuroPace	$12.76 +0.7%	$14.18	$9.22 ▼ $19.60	$434.89M	1.86	133,240 shs	127,171 shs
RCEL Avita Medical	$13.05 +0.5%	$9.77	$3.22 ▼ $13.49	$399.79M	1.99	316,724 shs	262,454 shs
SENS Senseonics Holdings, Inc. Common Stock	$9.16 -8.0%	$8.74	$4.79 ▼ $10.64	$416.36M	1.02	734,154 shs	635,903 shs
STXS Stereotaxis	$1.13 -1.7%	$1.34	$1.12 ▼ $3.59	$115.23M	1.37	546,739 shs	337,020 shs

7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NPCE NeuroPace	-4.16%	-9.11%	-14.97%	-24.49%	+17.64%
RCEL Avita Medical	-1.96%	+8.61%	+15.98%	+179.35%	+135.33%
SENS Senseonics Holdings, Inc. Common Stock	-3.39%	-0.90%	+3.43%	+87.57%	+995,999,900.00%
STXS Stereotaxis	-2.54%	-8.00%	-17.27%	-36.11%	-65.15%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
NPCE NeuroPace	$12.76 +0.7%	$14.18	$9.22 ▼ $19.60	$434.89M	1.86	133,240 shs	127,171 shs
RCEL Avita Medical	$13.05 +0.5%	$9.77	$3.22 ▼ $13.49	$399.79M	1.99	316,724 shs	262,454 shs
SENS Senseonics Holdings, Inc. Common Stock	$9.16 -8.0%	$8.74	$4.79 ▼ $10.64	$416.36M	1.02	734,154 shs	635,903 shs
STXS Stereotaxis	$1.13 -1.7%	$1.34	$1.12 ▼ $3.59	$115.23M	1.37	546,739 shs	337,020 shs

7 Stocks That Will Be Magnificent in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
NPCE NeuroPace	-4.16%	-9.11%	-14.97%	-24.49%	+17.64%
RCEL Avita Medical	-1.96%	+8.61%	+15.98%	+179.35%	+135.33%
SENS Senseonics Holdings, Inc. Common Stock	-3.39%	-0.90%	+3.43%	+87.57%	+995,999,900.00%
STXS Stereotaxis	-2.54%	-8.00%	-17.27%	-36.11%	-65.15%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
NPCE NeuroPace	2.80	Moderate Buy	$19.33	51.52% Upside
RCEL Avita Medical	2.57	Moderate Buy	$11.40	-12.64% Downside
SENS Senseonics Holdings, Inc. Common Stock	2.33	Hold	$13.00	41.92% Upside
STXS Stereotaxis	3.00	Buy	$3.50	209.73% Upside

Current Analyst Ratings Breakdown

Latest STXS, NPCE, SENS, and RCEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/7/2026	SENS Senseonics Holdings, Inc. Common Stock	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Equal Weight	$10.00
10/2/2026	NPCE NeuroPace	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/21/2026	NPCE NeuroPace	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/21/2026	RCEL Avita Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/17/2026	NPCE NeuroPace	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$18.00
9/17/2026	SENS Senseonics Holdings, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/17/2026	NPCE NeuroPace	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$18.00
9/15/2026	NPCE NeuroPace	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$21.00
9/15/2026	NPCE NeuroPace	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
8/28/2026	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $12.00
8/27/2026	STXS Stereotaxis	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform

(Data available from 10/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
NPCE NeuroPace	$99.99M	4.38	N/A	N/A	$0.57 per share	22.39
RCEL Avita Medical	$71.61M	5.61	N/A	N/A	($0.55) per share	-23.73
SENS Senseonics Holdings, Inc. Common Stock	$35.26M	10.86	N/A	N/A	$1.49 per share	6.15
STXS Stereotaxis	$32.38M	3.50	N/A	N/A	$0.14 per share	8.07

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
NPCE NeuroPace	-$21.47M	-$0.57	N/A	N/A	N/A	-19.34%	-105.64%	-16.51%	11/3/2026 (Estimated)
RCEL Avita Medical	-$48.59M	-$1.44	N/A	N/A	N/A	-56.96%	N/A	-78.53%	11/5/2026 (Estimated)
SENS Senseonics Holdings, Inc. Common Stock	-$69.11M	-$2.23	N/A	N/A	N/A	-225.09%	-165.80%	-80.14%	N/A
STXS Stereotaxis	-$21.64M	-$0.28	N/A	N/A	N/A	-74.24%	-130.84%	-29.23%	11/10/2026 (Estimated)

Latest STXS, NPCE, SENS, and RCEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/3/2026	Q3 2026	NPCE NeuroPace	-$0.1141	N/A	N/A	N/A	$27.14 million	N/A
8/11/2026	Q2 2026	NPCE NeuroPace	-$0.2179	-$0.18	+$0.0379	-$0.18	$22.61 million	$22.83 million
8/11/2026	Q2 2026	STXS Stereotaxis	-$0.05	-$0.05	N/A	-$0.05	$8.35 million	$7.67 million
8/6/2026	Q2 2026	RCEL Avita Medical	-$0.2928	-$0.25	+$0.0428	-$5.00	$20.25 million	$21.70 million
8/6/2026	Q2 2026	SENS Senseonics Holdings, Inc. Common Stock	-$0.55	-$0.63	-$0.08	-$0.63	N/A	$14.48 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
NPCE NeuroPace	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A
SENS Senseonics Holdings, Inc. Common Stock	N/A	N/A	N/A	N/A	N/A
STXS Stereotaxis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
NPCE NeuroPace	4.97	4.94	3.91
RCEL Avita Medical	N/A	0.41	0.34
SENS Senseonics Holdings, Inc. Common Stock	0.62	6.74	6.40
STXS Stereotaxis	N/A	1.42	0.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
NPCE NeuroPace	78.83%
RCEL Avita Medical	27.66%
SENS Senseonics Holdings, Inc. Common Stock	12.36%
STXS Stereotaxis	45.35%

Insider Ownership

Company	Insider Ownership
NPCE NeuroPace	19.20%
RCEL Avita Medical	2.24%
SENS Senseonics Holdings, Inc. Common Stock	4.70%
STXS Stereotaxis	16.03%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
NPCE NeuroPace	220	34.32 million	27.73 million	Optionable
RCEL Avita Medical	226	30.78 million	30.09 million	Optionable
SENS Senseonics Holdings, Inc. Common Stock	130	41.80 million	39.84 million	N/A
STXS Stereotaxis	131	100.20 million	84.14 million	Not Optionable

STXS, NPCE, SENS, and RCEL Headlines

Recent News About These Companies

Stereotaxis (NYSEAMERICAN:STXS) Trading Down 2.3% - Here's Why

September 17, 2026 | marketbeat.com

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026

September 16, 2026 | markets.businessinsider.com

Stereotaxis Flat Ahead of Atlanta Heart Conference

September 16, 2026 | baystreet.ca

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society's HRX 2026

September 16, 2026 | globenewswire.com

Stereotaxis: A Real Product Story, But The Stock Already Prices In Success

September 5, 2026 | seekingalpha.com

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

September 3, 2026 | globenewswire.com

Stereotaxis, Inc. (STXS) Stock Price, News, Quote & History - Yahoo Finance

September 1, 2026 | finance.yahoo.com

Stereotaxis (STXS) Q2 2026 Earnings Call Transcript

August 19, 2026 | finance.yahoo.com

Stereotaxis misses on Q2 revenue, cuts back 2026 guidance

August 13, 2026 | massdevice.com

Stereotaxis, Inc.: Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

August 12, 2026 | finanznachrichten.de

Stereotaxis expects recurring revenue to reach $8M in Q4 2026 as MAGiC adoption remains supply constrained

August 12, 2026 | seekingalpha.com

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2026 | zacks.com

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

August 11, 2026 | globenewswire.com

Stereotaxis, Inc. (STXS) latest stock news and headlines – Yahoo Finance

August 10, 2026 | uk.finance.yahoo.com

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

July 21, 2026 | markets.businessinsider.com

Stereotaxis, Inc.: University of Szeged Pioneers First Robotic Cardiology Program in Hungary

July 20, 2026 | finanznachrichten.de

Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings

July 20, 2026 | finance.yahoo.com

University of Szeged Pioneers First Robotic Cardiology Program in Hungary

July 20, 2026 | globenewswire.com

STXS Share News Today

July 9, 2026 | uk.investing.com

Stereotaxis Completes Acquisition of Robocath

July 9, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

STXS, NPCE, SENS, and RCEL Company Descriptions

NeuroPace NASDAQ:NPCE

$12.76 +0.09 (+0.71%)

Closing price 04:00 PM Eastern

Extended Trading

$12.76 +0.01 (+0.04%)

As of 07:30 PM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Avita Medical NASDAQ:RCEL

$13.05 +0.06 (+0.46%)

Closing price 04:00 PM Eastern

Extended Trading

$12.99 -0.06 (-0.45%)

As of 07:52 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

$9.16 -0.80 (-8.03%)

Closing price 04:00 PM Eastern

Extended Trading

$9.32 +0.16 (+1.80%)

As of 07:46 PM Eastern

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Stereotaxis NYSEAMERICAN:STXS

$1.13 -0.02 (-1.74%)

Closing price 04:10 PM Eastern

Extended Trading

$1.15 +0.02 (+1.86%)

As of 07:59 PM Eastern

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STXS, NPCE, SENS, and RCEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STXS, NPCE, SENS, and RCEL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STXS, NPCE, SENS, and RCEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

STXS, NPCE, SENS, and RCEL Company Descriptions

NeuroPace NASDAQ:NPCE

Avita Medical NASDAQ:RCEL

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

Stereotaxis NYSEAMERICAN:STXS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STXS, NPCE, SENS, and RCEL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STXS, NPCE, SENS, and RCEL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STXS, NPCE, SENS, and RCEL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

STXS, NPCE, SENS, and RCEL Company Descriptions

NeuroPace NASDAQ:NPCE

Avita Medical NASDAQ:RCEL

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

Stereotaxis NYSEAMERICAN:STXS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools